223 related articles for article (PubMed ID: 21875645)
1. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.
Fenoglio C; Cantoni C; De Riz M; Ridolfi E; Cortini F; Serpente M; Villa C; Comi C; Monaco F; Mellesi L; Valzelli S; Bresolin N; Galimberti D; Scarpini E
Neurosci Lett; 2011 Oct; 504(1):9-12. PubMed ID: 21875645
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.
Lindberg RL; Hoffmann F; Mehling M; Kuhle J; Kappos L
Eur J Immunol; 2010 Mar; 40(3):888-98. PubMed ID: 20148420
[TBL] [Abstract][Full Text] [Related]
3. miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients.
Lorenzi JC; Brum DG; Zanette DL; de Paula Alves Souza A; Barbuzano FG; Dos Santos AC; Barreira AA; da Silva WA
Int J Neurosci; 2012 Aug; 122(8):466-71. PubMed ID: 22463747
[TBL] [Abstract][Full Text] [Related]
4. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
[TBL] [Abstract][Full Text] [Related]
6. Differential microRNA expression in blood in multiple sclerosis.
Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
[TBL] [Abstract][Full Text] [Related]
7. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
8. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
[TBL] [Abstract][Full Text] [Related]
9. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
10. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
[TBL] [Abstract][Full Text] [Related]
11. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.
Gillett A; Thessen Hedreul M; Khademi M; Espinosa A; Beyeen AD; Jagodic M; Kockum I; Harris RA; Olsson T
Mult Scler; 2010 Sep; 16(9):1056-65. PubMed ID: 20354066
[TBL] [Abstract][Full Text] [Related]
13. Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.
Sievers C; Meira M; Hoffmann F; Fontoura P; Kappos L; Lindberg RL
Clin Immunol; 2012 Jul; 144(1):70-9. PubMed ID: 22659298
[TBL] [Abstract][Full Text] [Related]
14. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.
Pastrello C; Polesel J; Della Puppa L; Viel A; Maestro R
Carcinogenesis; 2010 Dec; 31(12):2124-6. PubMed ID: 20810544
[TBL] [Abstract][Full Text] [Related]
15. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
16. Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response.
Spinelli SV; Diaz A; D'Attilio L; Marchesini MM; Bogue C; Bay ML; Bottasso OA
Mol Immunol; 2013 Mar; 53(3):265-9. PubMed ID: 22964481
[TBL] [Abstract][Full Text] [Related]
17. The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma.
Yamashita J; Iwakiri T; Fukushima S; Jinnin M; Miyashita A; Hamasaki T; Makino T; Aoi J; Masuguchi S; Inoue Y; Ihn H
Melanoma Res; 2013 Feb; 23(1):13-20. PubMed ID: 23222547
[TBL] [Abstract][Full Text] [Related]
18. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients.
Voellenkle C; van Rooij J; Cappuzzello C; Greco S; Arcelli D; Di Vito L; Melillo G; Rigolini R; Costa E; Crea F; Capogrossi MC; Napolitano M; Martelli F
Physiol Genomics; 2010 Aug; 42(3):420-6. PubMed ID: 20484156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
